TITLE

Clinical Improvement After Duodenojejunal Bypass for Nonobese Type 2 Diabetes Despite Minimal Improvement in Glycemic Homeostasis

AUTHOR(S)
Ferzli, G. S.; Dominique, E.; Ciaglia, M.; Bluth, M. H.; Gonzalez, A.; Fingerhut, A.
PUB. DATE
May 2009
SOURCE
World Journal of Surgery;May2009, Vol. 33 Issue 5, p972
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Glycemic control of type 2 diabetes mellitus (T2DM) remains a dilemma to physicians. Although gastric bypass surgery undertaken for morbid obesity has been shown to resolve this disease well, data on the effectiveness of duodenojejunal bypass in improving or resolving T2DM and the metabolic syndrome (MS), especially in nonobese patients are scarce. This study was intended to evaluate the clinical effects of laparoscopic duodenojejunal bypass (LDJB) in patients with T2DM and a body mass index of <35 kg/m2. We conducted a 12-month prospective study on the changes in glucose homeostasis and the MS in seven T2DM subjects undergoing LDJB with similar DM duration, type of DM treatment, and glycemic control. Laboratory values including glycosylated hemoglobin A (HbA1c), fasting blood glucose, cholesterol, triglyceride, and C-peptide were followed throughout the 12 months. Serum levels of gastric inhibitory peptide and ghrelin were followed for 1 month. Serum levels of gastrin and glucagon-like peptide were followed for 3 months. At 12 months after surgery, all subjects consistently felt relief from fatigue, pain and/or numbness in the extremities, polyuria, and polydypsia. Clinical resolution was obtained for one patient, and the preoperative diabetic medication requirements decreased for most of the other patients. The subjects demonstrated an overall improved HbA1c (from 9.4% to 8.5%) and fasting blood glucose level (from 209 to 154 mg/dl). Although the change in fasting blood glucose approached statistical significance, these measures of glucose homeostasis did not achieve significance. Cholesterol and triglycerides increased slightly, and C-peptide decreased slightly over 1 year. These changes were not statistically significant. Although this is a small series, our data show that at 12 months after surgery, clinical improvement was obvious in all of our seven patients, but LDJB may not be effective at inducing remission of T2DM and the MS in certain patients undergoing this operation. This suggests that larger patient studies should be conducted, before concluding that surgery may offer clinical and biochemical resolution to a disease once treated only medically. Longer follow-up is required for better evaluation.
ACCESSION #
37827223

 

Related Articles

  • CHECK FOR DEAD WEIGHT.  // Men's Health;Nov2007, Vol. 22 Issue 9, p54 

    The article deals with a study published in the journal "Cell Metabolism," concerning visceral fat. The research has found that as visceral fat increases, so does RBP4, a blood protein linked to heart-disease risk and diabetes. The test should be available shortly, although an RBP4-lowering drug...

  • Clinical characteristics and outcome of multiple sclerosis in Korea: does multiple sclerosis in Korea really differ from that in the Caucasian populations? Kim, Su-Hyun; Huh, So-Young; Kim, Woojun; Park, Min Su; Ahn, Suk-Won; Cho, Joong-Yang; Kim, Byung Jo; Kim, Ho Jin // Multiple Sclerosis Journal;Oct2013, Vol. 19 Issue 11, p1493 

    The article presents a study on the clinical attributes and consequences of multiple sclerosis (MS) in South Korea. It mentions that researches were conducted in Asia without proper differentiation of neuromyelitis optica (NMO) from the autoimmune disorder. It also notes that the exclusion of...

  • Low Levels of Awareness of Suboptimal Health Conditions in a High-Risk Working Population: The 'Better Health for Better Hong Kong' Health Promotion Campaign. Ko, Gary T. C.; Chan, Juliana C. N.; Chan, Amy W. Y.; Wong, Patrick T. S.; Hui, Stanley S. C.; Tong, Spencer D. Y.; Chow, Ferrie; Chan, Cecilia L.W. // International Journal of Behavioral Medicine;Jun2007, Vol. 14 Issue 2, p63 

    The incidences of cardiovascular risk factors such as obesity and diabetes are rising in many Asian populations. In April 2000, a 5-year territory-wide health promotion campaign supported by Li Ka Shing Foundation was launched in Hong Kong by the Health InfoWorld of Hospital Authority. From the...

  • Better risk assessment with glycated hemoglobin instead of cholesterol in CVD risk prediction charts. Faeh, David; Rohrmann, Sabine; Braun, Julia // European Journal of Epidemiology;Jul2013, Vol. 28 Issue 7, p551 

    Traditional risk charts for the prediction of cardiovascular disease (CVD) include cholesterol parameters. We evaluated how models predict fatal CVD when cholesterol is replaced by glucose parameters. We used data from NHANES III, a US survey conducted 1988-1994 (follow-up until 2006); 15,454...

  • Metabolic Syndrome - Risk Factors for Atherosclerosis and Diabetes. Mihic, Marko; Modi, Pankaj // Current Diabetes Reviews;2008, Vol. 4 Issue 2, p122 

    Objective: To evaluate the lipoprotein profiles, triglycerides and glycemia along with the abdominal fat to explore the risk factors associated with non-diabetic state to IGF, IGT and Type-2 diabetes in Canadian population. Methods: We examined 780 subjects using the ADA and WHO criteria to...

  • How can I prevent diabetes kidney problems?  // Prevent Diabetes Problems: Keep Your Kidneys Healthy (National D;Feb2010, p4 

    The article discusses the ways to prevent diabetes kidney problems. It suggests to keep blood sugar to normal levels, to keep blood pressure under control to prevent kidney damage, and to keep informed decisions on medications. It further suggests to follow a healthy eating plan, to check the...

  • The ABCs of Diabetes. Gorman, Christine // Time;4/14/2003, Vol. 161 Issue 15, p104 

    Reports that the American College of Physicians have issued new guidelines for the treatment of diabetes. Role of blood pressure and cholesterol levels in the treatment of diabetes; Risk factors associated with diabetes including blindness and kidney disease; Number of Americans with Type 2...

  • A case–control study of risk factors for multiple sclerosis in Iran. Alonso, Alvaro; Cook, Stuart D.; Maghzi, Amir-Hadi; Divani, Afshin A. // Multiple Sclerosis Journal;May2011, Vol. 17 Issue 5, p550 

    Background: Numerous studies have assessed risk factors for multiple sclerosis (MS), although none have been conducted previously in Iran.Objective: The objective of this study was to study lifestyle and environmental risk factors of MS in the Iranian population.Methods: A case–control...

  • A nationwide survey of the prevalence of multiple sclerosis in immigrant populations of Sweden. Ahlgren, Cecilia; Odén, Anders; Lycke, Jan // Multiple Sclerosis Journal;Aug2012, Vol. 18 Issue 8, p1099 

    The article discusses a study which investigated multiple sclerosis (MS) prevalence in immigrants of Sweden. The study used the information on foreign-born patients from Swedish population and national health registers. It notes that the prevalence of MS increased in those who came from...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics